Drug intelligence / Profile preview

Blink

Development stage
Phase 4
Lead developer
Bp Consulting
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Blink is a brand of over-the-counter lubricant eye drops (artificial tears) primarily used to provide temporary relief from ocular dryness, burning, and irritation. The formulation typically utilizes polyethylene glycol 400 (PEG 400) as a demulcent, which functions by stabilizing the tear film and increasing moisture retention on the ocular surface. In the context of clinical research sponsored by Bp Consulting, Inc., Blink was evaluated in a Phase 4 trial (NCT00703300) as an adjunct or control intervention for patients with diabetic macular edema (DME) undergoing argon laser therapy. In this capacity, it serves as a moisturizing agent to maintain ocular surface integrity and comfort during the treatment of retinal vascular disorders, often serving as a comparator to active pharmaceutical interventions like bromfenac.

Brand names
BlinkBlink TearsBlink ContactsBlink GelTears
Other names
Polyethylene glycol 400PEG 400PEG400PEG-400

Beyond the preview

Go deeper on Blink.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blink.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call